APA (7th ed.) Citation

Singh, R., Gulani, M., Vijayanand, S., Arte, T., Adediran, E., Pasupuleti, D., . . . D'souza, M. J. (2025). An intranasal quadruple variant vaccine approach using SARS-CoV-2 and influenza A: Delta, Omicron, H1N1and H3N2. International Journal of Pharmaceutics, 683, N.PAG. https://doi.org/10.1016/j.ijpharm.2025.126043

Chicago Style (17th ed.) Citation

Singh, Revanth, et al. "An Intranasal Quadruple Variant Vaccine Approach Using SARS-CoV-2 and Influenza A: Delta, Omicron, H1N1and H3N2." International Journal of Pharmaceutics 683 (2025): N.PAG. https://doi.org/10.1016/j.ijpharm.2025.126043.

MLA (9th ed.) Citation

Singh, Revanth, et al. "An Intranasal Quadruple Variant Vaccine Approach Using SARS-CoV-2 and Influenza A: Delta, Omicron, H1N1and H3N2." International Journal of Pharmaceutics, vol. 683, 2025, p. N.PAG, https://doi.org/10.1016/j.ijpharm.2025.126043.